Neurorestorative Therapy of Stroke in Type 2 Diabetes Mellitus Rats Treated with Human Umbilical Cord Blood Cells

Stroke

Volumn 46, Issue 9, 2015, Pages 2599-2606

  Yan, Tao ^a,b   Venkat, Poornima ^a,c   Chopp, Michael ^a,c   Zacharek, Alex ^a   Ning, Ruizhuo ^a   Cui, Yisheng ^a   Roberts, Cynthia ^a   Kuzmin Nichols, Nicole ^d   Sanberg, Cyndy Davis ^d   Chen, Jieli ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c OAKLAND UNIVERSITY   (United States)

^d Saneron CCEL Therapeutics Inc   (United States)

Author keywords

diabetes mellitus, type 2; human umbilical cord blood; infarction, middle cerebral artery; matrix metalloproteinase 9; neurorestorative therapy; stroke; vascular remodeling

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; CD163 ANTIGEN; GELATINASE B; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; VON WILLEBRAND FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EMBRYO CELL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD BLOOD CELL; MACROPHAGE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL PLASTICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR REMODELING; WHITE MATTER; ANIMAL; BRAIN ISCHEMIA; COMPLICATION; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODEL; INFARCTION, MIDDLE CEREBRAL ARTERY; PROCEDURES; STROKE; WISTAR RAT;

ANIMALS; BRAIN ISCHEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, WISTAR; STROKE;

EID: 84940398519     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009870     Document Type: Article

References (42)

1. Chen J, Cui X, Zacharek A, Cui Y, Roberts C, Chopp M. White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke. 2011;42:445-452. doi: 10.1161/STROKEAHA.110.596486.
2. Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, et al; SPARCL Investigators. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol. 2011;68:1245-1251. doi: 10.1001/archneurol.2011.146.
3. Hurtado O, Pradillo JM, Alonso-Escolano D, Lorenzo P, Sobrino T, Castillo J, et al. Neurorepair versus neuroprotection in stroke. Cerebrovasc Dis. 2006;21(suppl 2):54-63. doi: 10.1159/000091704.
4. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682-2688.
5. Newman MB, Willing AE, Manresa JJ, Davis-Sanberg C, Sanberg PR. Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. Stem Cells Dev. 2005;14:576-586. doi: 10.1089/scd.2005.14.576.
6. Yan T, Venkat P, Ye X, Chopp M, Zacharek A, Ning R, et al. HUCBCs increase angiopoietin 1 and induce neurorestorative effects after stroke in T1DM rats. CNS Neurosci Ther. 2014;20:935-944. doi: 10.1111/cns.12307.
7. Cui X, Chopp M, Zacharek A, Ye X, Roberts C, Chen J. Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol Dis. 2011;43:285-292. doi: 10.1016/j. nbd.2011.04.005.
8. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32:1005-1011.
9. Chen H, Chopp M, Zhang ZG, Garcia JH. The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1992;12:621-628. doi: 10.1038/jcbfm.1992.86.
10. Rogers DC, Campbell CA, Stretton JL, Mackay KB. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke. 1997;28:2060-2065, discussion 2066.
11. Ye X, Yan T, Chopp M, Zacharek A, Ning R, Venkat P, et al. Combination BMSC and Niaspan treatment of stroke enhances white matter remodeling and synaptic protein expression in diabetic rats. Int J Mol Sci. 2013;14:22221-22232. doi: 10.3390/ijms141122221.
12. Yan T, Ye X, Chopp M, Zacharek A, Ning R, Venkat P, et al. Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats. PLoS One. 2013;8:e81199. doi: 10.1371/journal.pone.0081199.
13. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003;53:743-751. doi: 10.1002/ana.10555.
14. Zacharek A, Chen J, Cui X, Yang Y, Chopp M. Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke. Stroke. 2009;40:254-260. doi: 10.1161/STROKEAHA.108.524116.
15. Newcomb JD, Sanberg PR, Klasko SK, Willing AE. Umbilical cord blood research: current and future perspectives. Cell Transplant. 2007;16:151-158.
16. Chen J, Ye X, Yan T, Zhang C, Yang XP, Cui X, et al. Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke. 2011;42:3551-3558. doi: 10.1161/STROKEAHA.111.627174.
17. Ning R, Chopp M, Yan T, Zacharek A, Zhang C, Roberts C, et al. Tissue plasminogen activator treatment of stroke in type-1 diabetes rats. Neuroscience. 2012;222:326-332. doi: 10.1016/j.neuroscience.2012.07.018.
18. Ding G, Yan T, Chen J, Chopp M, Li L, Li Q, et al. Persistent cerebrovascular damage after stroke in type two diabetic rats measured by magnetic resonance imaging. Stroke. 2015;46:507-512. doi: 10.1161/STROKEAHA.114.007538.
19. Jickling GC, Liu D, Stamova B, Ander BP, Zhan X, Lu A, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34:185-199. doi: 10.1038/jcbfm.2013.203.
20. Kuntz M, Mysiorek C, Pétrault O, Pétrault M, Uzbekov R, Bordet R, et al. Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo/in vitro study. J Cereb Blood Flow Metab. 2014;34:95-107. doi: 10.1038/jcbfm.2013.169.
21. Liu J, Wang Y, Akamatsu Y, Lee CC, Stetler RA, Lawton MT, et al. Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials. Prog Neurobiol. 2014;115:138-156. doi: 10.1016/j. pneurobio.2013.11.004.
22. Cui X, Chopp M, Zacharek A, Dai J, Zhang C, Yan T, et al. Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome. Neuroscience. 2012;227:223-231. doi: 10.1016/j. neuroscience.2012.09.066.
23. Liu Z, Li Y, Zhang ZG, Cui X, Cui Y, Lu M, et al. Bone marrow stromal cells enhance inter-and intracortical axonal connections after ischemic stroke in adult rats. J Cereb Blood Flow Metab. 2010;30:1288-1295. doi: 10.1038/jcbfm.2010.8.
24. Ueno Y, Chopp M, Zhang L, Buller B, Liu Z, Lehman NL, et al. Axonal outgrowth and dendritic plasticity in the cortical peri-infarct area after experimental stroke. Stroke. 2012;43:2221-2228. doi: 10.1161/STROKEAHA.111.646224.
25. Yan T, Chopp M, Ye X, Liu Z, Zacharek A, Cui Y, et al. Niaspan increases axonal remodeling after stroke in type 1 diabetes rats. Neurobiol Dis. 2012;46:157-164. doi: 10.1016/j.nbd.2012.01.001.
26. Schmidt RE. Neuropathology and pathogenesis of diabetic autonomic neuropathy. Int Rev Neurobiol. 2002;50:257-292.
27. Walmsley AR, Mir AK. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Curr Pharm Des. 2007;13:2470-2484.
28. Tanaka K, Nogawa S, Suzuki S, Dembo T, Kosakai A. Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain. Brain Res. 2003;989:172-179.
29. Chen J, Zacharek A, Cui X, Shehadah A, Jiang H, Roberts C, et al. Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice. J Cereb Blood Flow Metab. 2010;30:102-109. doi: 10.1038/jcbfm.2009.187.
30. Kim JY, Kawabori M, Yenari MA. Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Curr Med Chem. 2014;21:2076-2097.
31. Whitney NP, Eidem TM, Peng H, Huang Y, Zheng JC. Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem. 2009;108:1343-1359. doi: 10.1111/j.1471-4159.2009.05886.x.
32. Kriz J. Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol. 2006;18:145-157.
33. Kumari R, Willing LB, Patel SD, Baskerville KA, Simpson IA. Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke. J Neurochem. 2011;119:1029-1040. doi: 10.1111/j.1471-4159.2011.07487.x.
34. Ye X, Chopp M, Liu X, Zacharek A, Cui X, Yan T, et al. Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats. Neuroscience. 2011;190:339-345. doi: 10.1016/j.neuroscience.2011.06.004.
35. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108:949-955. doi: 10.1172/JCI14002.
36. Qiu J, Xu J, Zheng Y, Wei Y, Zhu X, Lo EH, et al. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke. 2010;41:2077-2082. doi: 10.1161/STROKEAHA.110.590463.
37. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435-13444. doi: 10.1523/JNEUROSCI.3257-09.2009.
38. Jin Q, Cheng J, Liu Y, Wu J, Wang X, Wei S, et al. Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke. Brain Behav Immun. 2014;40:131-142.
39. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43:3063-3070. doi: 10.1161/STROKEAHA.112.659656.
40. Perego C, Fumagalli S, De Simoni M-G. Three-dimensional confocal analysis of microglia/macrophage markers of polarization in experimental brain injury. J Vis Exp. 2013;(79):e50605. doi: 10.3791/50605.
41. Michalski D, Heindl M, Kacza J, Laignel F, Küppers-Tiedt L, Schneider D, et al. Spatio-temporal course of macrophage-like cell accumulation after experimental embolic stroke depending on treatment with tissue plasminogen activator and its combination with hyperbaric oxygenation. Eur J Histochem. 2012;56:e14. doi: 10.4081/ejh.2012.14.
42. Karki K, Knight RA, Shen LH, Kapke A, Lu M, Li Y, et al. Chronic brain tissue remodeling after stroke in rat: a 1-year multiparametric magnetic resonance imaging study. Brain Res. 2010;1360:168-176. doi: 10.1016/j.brainres.2010.08.098.